| Patents for C07K 16 - Immunoglobulins, e.g. monoclonal or polyclonal antibodies (149,320) |
|---|
| 06/02/2009 | US7541160 Detection of isoforms of vascular endothelial growth factor sample; obtain sample containing vascular endothelial growth factor, incubate with binding protein conjugated to solid support, expose to antibody, detect bound growth factor |
| 06/02/2009 | US7541154 GASP1: a follistatin domain containing protein |
| 06/02/2009 | US7541149 Monoclonal antibody and assay for detecting PIIINP |
| 06/02/2009 | US7541036 Human immunodeficiency virus type 1 (HIV-1) matrix (MA or p17) polypeptide capable of inducing anti-p17 antibodies that neutralize the proinflammatory activities of the MA protein |
| 06/02/2009 | US7541034 Recombinant antibodies and immunoconjugates targeted to CD-22 bearing cells and tumors |
| 06/02/2009 | US7541033 Humanized anti-IL-1β antibodies |
| 06/02/2009 | US7541032 Antigen uptake receptor for Candida albicans on dendritic cells |
| 06/02/2009 | US7541031 Methods for treating rheumatoid arthritis using human antibodies that bind human TNFα |
| 06/02/2009 | US7541030 Antibodies for identifying and/or isolating at least one cell population which is selected from the group comprising haematopoietic stem cells, neuronal stem cells, neuronal precursor cells, mesenchymal stem cells and mesenchymal precursor cells |
| 06/02/2009 | US7541029 Anti-rhesus D monoclonal antibodies |
| 06/02/2009 | US7541027 polyclonal antibodies, monoclonal antibodies, F(ab')2, Fab and single chain Fv; tyrosine at position 1214 in the amino acid sequence of the vascular endothelial growth factor receptor |
| 06/02/2009 | CA2335937C Azaftig, a proteoglycan for monitoring cachexia and for control of obesity |
| 06/02/2009 | CA2285919C Diagnostic tests and kits for clostridium difficile |
| 06/02/2009 | CA2274495C Uspa1 and uspa2 antigens of moraxella catarrhalis |
| 06/02/2009 | CA2249351C Novel method of diagnosing and treating gliomas |
| 05/30/2009 | CA2618374A1 Trimeric collagen scaffold antibodies |
| 05/28/2009 | WO2009067660A2 Anti-factor xi monoclonal antibodies and methods of use thereof |
| 05/28/2009 | WO2009067642A2 Removing polypeptides from stool |
| 05/28/2009 | WO2009067520A2 Peptides specific for hepatocellular carcinoma cells and applications thereof |
| 05/28/2009 | WO2009067429A1 Compositions and methods for inhibiting tumor progression |
| 05/28/2009 | WO2009067242A2 Co-crystal of antibody 11f8 fab fragment and egfr extracellular domain and uses thereof |
| 05/28/2009 | WO2009066702A1 Anti-hiv monoclonal antibody |
| 05/28/2009 | WO2009066655A1 Human antibody capable of inducing apoptosis |
| 05/28/2009 | WO2009066241A1 Antibody fragments inhibiting hiv nef protein |
| 05/28/2009 | WO2009065414A1 A method for characterization of a recombinant polyclonal protein |
| 05/28/2009 | WO2009035804A3 Gene silencing of the brother of the regulator of imprinted sites (boris) |
| 05/28/2009 | WO2009032782A3 Compositions that bind multiple epitopes of igf-1r |
| 05/28/2009 | WO2009031151A3 Antibodies and methods for diagnosing and treating cancer |
| 05/28/2009 | WO2009029591A3 Monoclonal antibody which binds met in formalin-fixed and paraffin-embedded tissues and related methods |
| 05/28/2009 | WO2008156713A3 Anti-cd20 therapeutic compositions and methods |
| 05/28/2009 | WO2008146164A3 Streptococcus pneumoniae pilus antigens |
| 05/28/2009 | WO2008051980A8 Methods of reducing phosphate absorption |
| 05/28/2009 | WO2008051977A8 Methods of reducing phosphate absorption |
| 05/28/2009 | WO2007067596A3 Methods and compositions for needleless delivery of antibodies |
| 05/28/2009 | WO2006023248A3 Processes for producing and crystallizing g-protein coupled receptors |
| 05/28/2009 | US20090138977 Pancreatic cancer targets and uses thereof |
| 05/28/2009 | US20090137788 Nucleotide sequences coding bacterial cell surface proteins for use in generating monoclonal antibodies for prevention and treatment of infection |
| 05/28/2009 | US20090137787 Janus family kinases and identification of immune modulators |
| 05/28/2009 | US20090137784 Epidermal Growth Factor Receptor Polypeptides and Antibodies |
| 05/28/2009 | US20090137783 CNGH0010 Specific Polynucleotides, Polypeptides, Antibodies, Compositions, Methods and Uses |
| 05/28/2009 | US20090137782 Recognize aberrant glycosylated form of the EGFR; evident upon aberrant post-translational modification; cancer |
| 05/28/2009 | US20090137778 A HIV peptide consisting of 23 to 50 amino acid residues; trans-activator |
| 05/28/2009 | US20090137502 Riproximin, a Novel Type II Ribosome-Inactivating Protein and Uses Thereof |
| 05/28/2009 | US20090137501 Resistance Genes |
| 05/28/2009 | US20090137419 Sequencing of surface immobilized polymers utilizing microfluorescence detection |
| 05/28/2009 | US20090137051 Monoclonal Antibodies Directed Against The Microtubule-Associated Protein Tau |
| 05/28/2009 | US20090137036 Tweak receptor |
| 05/28/2009 | US20090137035 Tweak receptor |
| 05/28/2009 | US20090137033 Novel fluorescent proteins from aequorea coerulscens and methods for using same |
| 05/28/2009 | US20090136999 Compositions and methods for immunotherapy of cancer and infectious diseases |
| 05/28/2009 | US20090136998 Luciferases and methods for making and using the same |
| 05/28/2009 | US20090136997 Pro1550 polypeptides and nucleic acids encoding the same |
| 05/28/2009 | US20090136990 Methods for identifying substances for the treatment of alzheimer's disease |
| 05/28/2009 | US20090136985 Vascular Aging-Predicting Factor and Utilization of the Same |
| 05/28/2009 | US20090136983 Target sequences for synthetic molecules |
| 05/28/2009 | US20090136970 Nogo receptor homologues and their use |
| 05/28/2009 | US20090136969 Lipoprotein Associated Phospholipase A2, Inhibitors Thereof and Use of the Same in Diagnosis and Therapy |
| 05/28/2009 | US20090136964 Novel anti-heparan sulfate antibody, method for detection of heparan sulfate, and kit for detection of heparan sulfate |
| 05/28/2009 | US20090136962 Diagnostic markers for cancer |
| 05/28/2009 | US20090136959 Novel genes encoding proteins having prognostic, diagnostic preventive, therapeutic, and other uses |
| 05/28/2009 | US20090136936 Immunoglobulin fc libraries |
| 05/28/2009 | US20090136934 Targeting and tracing of antigens in living cells |
| 05/28/2009 | US20090136928 Compositions and Methods for the Diagnosis and Treatment of Tumor |
| 05/28/2009 | US20090136920 Diagnostics and therapeutics for diseases associated with serum/glucocorticoid regulated kinase 1 (sgk1) |
| 05/28/2009 | US20090136623 Growth inhibitory composition against pathogenic bacteria of meat based food stuff comprising igy |
| 05/28/2009 | US20090136552 Growth factors nsg28, nsg30, and nsg32 |
| 05/28/2009 | US20090136533 POLYPEPTIDE DERIVED FROM gp41, A VACCINE COMPOSITION COMPRISING SAID POLYPEPTIDE, AND USES FOR TREATING AN INFECTION BY AN HIV VIRUS IN AN INDIVIDUAL |
| 05/28/2009 | US20090136530 Influenza Hemagglutinin and Neuraminidase Variants |
| 05/28/2009 | US20090136526 CD19 Binding Agents and Uses Thereof |
| 05/28/2009 | US20090136524 Compositions and methods for diagnosis and treatment of tumors |
| 05/28/2009 | US20090136523 Anti-cd26 antibodies and methods of use thereof |
| 05/28/2009 | US20090136516 Cd-20 specific antibodies and methods of employing same |
| 05/28/2009 | US20090136511 an oligopeptide capable of binding cellular IL-15R alpha or its soluble fraction and inhibiting IL-15-dependent T cell proliferation activity, used for treating rheumatoid arthritis and psoriasis in a mammal; immunogens |
| 05/28/2009 | US20090136510 Inhibition of macrophage-stimulating protein receptor (RON) and methods of treatment thereof |
| 05/28/2009 | US20090136508 Method of diagnosing colon and gastric cancers |
| 05/28/2009 | US20090136507 HBM variants that modulate bone mass and lipid levels |
| 05/28/2009 | US20090136506 Conserved Membrane Activator of Calcineurin (CMAC), a Novel Therapeutic Protein and Target |
| 05/28/2009 | US20090136504 Diagnostic and therapeutic target PRKX proteins for neurodegenerative diseases |
| 05/28/2009 | US20090136503 Trail receptor-binding agents and uses of the same |
| 05/28/2009 | US20090136501 Compositions and methods for treating coagulation related disorders |
| 05/28/2009 | US20090136498 Method for Manufacturing Recombinant Polyclonal Proteins |
| 05/28/2009 | US20090136497 Methods for inhibiting cutaneous inflammation and hyperpigmentation |
| 05/28/2009 | US20090136495 useful therapeutically for increasing serum iron levels, reticulocyte count, red blood cell count, hemoglobin, and/or hematocrit in a human; anemia |
| 05/28/2009 | US20090136492 Therapy of ocular disorders |
| 05/28/2009 | US20090136491 IL-17 homologous polypeptides and therapeutic uses thereof |
| 05/28/2009 | US20090136490 Ovr110 antibody compositions and methods for use |
| 05/28/2009 | US20090136485 Methods and compositions for inhibiting CD32B expressing cells |
| 05/28/2009 | US20090136484 Novel antibody molecules and nucleic acids |
| 05/28/2009 | US20090136483 Compositions and Methods for Binding Lysophosphatidic Acid |
| 05/28/2009 | US20090136420 Neoplasm-specific polypeptides and their uses |
| 05/28/2009 | US20090136418 Peptides specific for hepatocellular carcinoma cells and applications thereof |
| 05/28/2009 | CA2705851A1 Anti-factor xi monoclonal antibodies and methods of use thereof |
| 05/28/2009 | CA2702462A1 Compositions and methods for inhibiting tumor progression |
| 05/28/2009 | CA2702322A1 A method for characterization of a recombinant polyclonal protein |
| 05/27/2009 | EP2062974A1 Method of producing fused protein |
| 05/27/2009 | EP2062920A2 Protein phosphorylation by basophilic serine/threonine kinases in insulin signalling pathways |
| 05/27/2009 | EP2062919A2 Pharmaceutical compositions and methods useful for modulating angiogenesis, inhibiting metastasis and tumor fibrosis, and assessing the malignancy of colon cancer tumors |
| 05/27/2009 | EP2062918A2 Pharmaceutical compositions and methods useful for modulating angiogenesis, inhibiting metastasis and tumor fibrosis, and assessing the malignancy of colon cancer tumors |
| 05/27/2009 | EP2062917A2 Antibodies to erythropoietin receptor and uses thereof |
| 05/27/2009 | EP2062916A2 Therapy of autoimmune disease in a patient with an inadequate response to a TNF-Alpha inhibitor |